TBK1: a new target for overcoming cancer immunotherapy resistance
Crossref DOI link: https://doi.org/10.1007/s11427-023-2395-y
Published Online: 2023-09-22
Published Print: 2024-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Guan, Jizhong
Zhang, Long
Zhou, Fangfang
Text and Data Mining valid from 2023-09-22
Version of Record valid from 2023-09-22
Article History
Received: 11 April 2023
Accepted: 13 June 2023
First Online: 22 September 2023
Conflict of Interest
: The author(s) declare that they have no conflict of interest.